Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.
Volume 31, Number 12—December 2025
Dispatch
Healthcare Worker Attitudes and Perceptions toward Ebola Vaccine, United States, 2024
Figure

Figure. Survey responses from study of healthcare worker attitudes and perceptions toward the Ebola vaccine, United States, 2024. A) Interest in receiving ERVEBO vaccine (Merck, https://www.merck.com) among eligible healthcare workers at New York City Health + Hospitals/Bellevue (New York, NY, USA); University of Texas Medical Branch (Galveston, TX, USA); and Denver Health and Hospital Authority (Denver, CO, USA) (n = 66). B) Preferred timing for receiving ERVEBO among survey respondents who indicated they were interested in receiving vaccine and not already vaccinated (n = 30).